Justin Shum
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Justin Shum has a total of 43 co-authors. Here are the top co-authors by number of shared publications:
- Kenneth Kam-Wing Lo
Department of Chemistry, City University of Hong Kong, Tat Chee Avenue, Hong Kong, P. R. China
13 shared publications - Lawrence Cho-Cheung Lee
Department of Chemistry, City University of Hong Kong, Tat Chee Avenue, Kowloon, Hong Kong, P. R. China
7 shared publications - Alex Man-Hei Yip
Department of Chemistry, City University of Hong Kong, Tat Chee Avenue, Kowloon, Hong Kong, P. R. China
5 shared publications - Peter Kam-Keung Leung
Department of Chemistry, City University of Hong Kong, Tat Chee Avenue, Kowloon, Hong Kong, P. R. China
4 shared publications - Guang-Xi Xu
Department of Chemistry, City University of Hong Kong, Tat Chee Avenue, Kowloon, Hong Kong, P. R. China
3 shared publications - Eunice Chiu-Lam Mak
Department of Chemistry, City University of Hong Kong, Tat Chee Avenue, Hong Kong, P. R. China
2 shared publications
Latest Publications
- Open Access
- 30 June 2026
- Published by American Chemical Society (ACS) in Journal of the American Chemical Society
- Vol. 148 (27) , 28238-28253
Enzyme-Responsive Chemiluminescent Probes Assembled with Iridium(III) Photosensitizers via Host–Guest Chemistry for Chemiluminescence-Induced Photodynamic Therapy
Photodynamic therapy (PDT) is effective for localized cancers, but its reliance on external light limits treatment depth and uniformity. Herein, we report a programmable supramolecular chemiluminescence (CL)-induced PDT platform that generates reactive oxygen species (ROS) in the absence of light irradiation and displays intrinsic cancer selectivity. This platform is constructed through the supramolecular interaction between enzyme-responsive chemiluminescent spiroadamantyl phenoxy-1,2-dioxetane probes (ADOP, ADOE, and ADOG) and luminescent iridium(III) complexes bearing a trimethyl-β-cyclodextrin (TMCD) host [Ir(N∧C)2(bpy-TMCD)](Cl) (HN∧C = 2-phenylpyridine (Hppy) (1a), 2-phenylquinoline (Hpq) (2a), and 2-(1-naphthyl)benzothiazole (Hbsn) (3a)). The chemiluminescent probes exhibited CL upon reaction with alkaline phosphatase (ALP), porcine liver esterase (PLE), and β-galactosidase (β-gal); while the iridium(III) complexes showed intense phosphorescence with efficient singlet oxygen production, distinct intracellular localization, and tunable (photo)cytotoxicity. In aqueous solutions, mixing the chemiluminescent probes with TMCD-tagged iridium(III) complexes afforded supramolecular adducts that, upon enzyme activation, underwent chemiluminescence resonance energy transfer (CRET) from the dioxetane donors to the iridium(III) acceptors. Remarkably, the ALP-responsive conjugate formed from probe ADOP and complex 3a (adduct ADOP–3a) selectively generated ROS and elicited potent cytotoxicity in cancerous HeLa cells and spheroids under light-free conditions, with apoptosis as the predominant cell death pathway, while remaining noncytotoxic in normal HEK293 cells. This modular platform couples supramolecular host–guest assembly, enzyme-specific activation, and CRET-induced ROS generation to overcome the limitations of conventional PDT, enabling cancer-selective, light-free therapy.
- 30 June 2026
- Published by American Chemical Society (ACS) in Journal of the American Chemical Society
- Vol. 148 (27) , 28238-28253
Open AccessEnzyme-Responsive Chemiluminescent Probes Assembled with Iridium(III) Photosensitizers via Host–Guest Chemistry for Chemiluminescence-Induced Photodynamic Therapy
Photodynamic therapy (PDT) is effective for localized cancers, but its reliance on external light limits treatment depth and uniformity. Herein, we report a programmable supramolecular chemiluminescence (CL)-induced PDT platform that generates reactive oxygen species (ROS) in the absence of light irradiation and displays intrinsic cancer selectivity. This platform is constructed through the supramolecular interaction between enzyme-responsive chemiluminescent spiroadamantyl phenoxy-1,2-dioxetane probes (ADOP, ADOE, and ADOG) and luminescent iridium(III) complexes bearing a trimethyl-β-cyclodextrin (TMCD) host [Ir(N∧C)2(bpy-TMCD)](Cl) (HN∧C = 2-phenylpyridine (Hppy) (1a), 2-phenylquinoline (Hpq) (2a), and 2-(1-naphthyl)benzothiazole (Hbsn) (3a)). The chemiluminescent probes exhibited CL upon reaction with alkaline phosphatase (ALP), porcine liver esterase (PLE), and β-galactosidase (β-gal); while the iridium(III) complexes showed intense phosphorescence with efficient singlet oxygen production, distinct intracellular localization, and tunable (photo)cytotoxicity. In aqueous solutions, mixing the chemiluminescent probes with TMCD-tagged iridium(III) complexes afforded supramolecular adducts that, upon enzyme activation, underwent chemiluminescence resonance energy transfer (CRET) from the dioxetane donors to the iridium(III) acceptors. Remarkably, the ALP-responsive conjugate formed from probe ADOP and complex 3a (adduct ADOP–3a) selectively generated ROS and elicited potent cytotoxicity in cancerous HeLa cells and spheroids under light-free conditions, with apoptosis as the predominant cell death pathway, while remaining noncytotoxic in normal HEK293 cells. This modular platform couples supramolecular host–guest assembly, enzyme-specific activation, and CRET-induced ROS generation to overcome the limitations of conventional PDT, enabling cancer-selective, light-free therapy.
- Open Access
- 7 January 2026
- Published by Wiley in ChemistryEurope
- Vol. 4 (1)
Revisiting Cu(I)‐Dppm Chemistry: Bright Thermally Activated Delayed Fluorescence Luminescence, Anion Dependance, Mechanochromism, and Singlet Oxygen Generation of a Dinuclear Cu(I) Homoleptic Complex
The one‐step syntheses of highly luminescent Cu(I) dimetallic complexes are reported using Cu(I) salts and the commercially available dppm ligand. Three crystalline phases A – C , obtained either with PF 6 − ( A and B : [Cu 2 (μ 2 ‐dppm) 3 ](PF 6 ) 2 ) or TEF − ( C : [Cu 2 (μ 2 ‐dppm) 3 ](TEF) 2 ) anions, display distinct conformations and crystal packings that strongly influence photophysical properties. All phases show intense solid‐state thermally activated delayed fluorescence with room temperature quantum yields of nearly 100%. Emission energies and decay times are modulated by packing effects. Phases A and B exhibit pronounced mechanochromic luminescence upon gentle grinding, while phase C is mechanically insensitive, presumably due to its bulky and flexible counter‐anions. Density functional calculation/time‐dependent density functional calculations suggest that crystal packing impacts the structural molecular relaxation, in agreement with mechanochromic behaviors. In aerated CH 2 Cl 2 , these complexes generate singlet oxygen with quantum yield of up to 30%, highlighting their potential as photosensitizers.
- 7 January 2026
- Published by Wiley in ChemistryEurope
- Vol. 4 (1)
Open AccessRevisiting Cu(I)‐Dppm Chemistry: Bright Thermally Activated Delayed Fluorescence Luminescence, Anion Dependance, Mechanochromism, and Singlet Oxygen Generation of a Dinuclear Cu(I) Homoleptic Complex
The one‐step syntheses of highly luminescent Cu(I) dimetallic complexes are reported using Cu(I) salts and the commercially available dppm ligand. Three crystalline phases A – C , obtained either with PF 6 − ( A and B : [Cu 2 (μ 2 ‐dppm) 3 ](PF 6 ) 2 ) or TEF − ( C : [Cu 2 (μ 2 ‐dppm) 3 ](TEF) 2 ) anions, display distinct conformations and crystal packings that strongly influence photophysical properties. All phases show intense solid‐state thermally activated delayed fluorescence with room temperature quantum yields of nearly 100%. Emission energies and decay times are modulated by packing effects. Phases A and B exhibit pronounced mechanochromic luminescence upon gentle grinding, while phase C is mechanically insensitive, presumably due to its bulky and flexible counter‐anions. Density functional calculation/time‐dependent density functional calculations suggest that crystal packing impacts the structural molecular relaxation, in agreement with mechanochromic behaviors. In aerated CH 2 Cl 2 , these complexes generate singlet oxygen with quantum yield of up to 30%, highlighting their potential as photosensitizers.
- 4 December 2025
- Published by Royal Society of Chemistry (RSC) in Chemical Communications
- Vol. 61 (98) , 19461-19464
A matrix metalloproteinase-responsive iridium( iii )-based hydrogel for cancer cell-specific imaging and lysosome-targeted photodynamic therapy
A matrix metalloproteinase-sensitive iridium( iii )-based hydrogel selectively delivered lysosome-targeting iridium( iii ) complexes to cancer cells in response to elevated enzyme activity, offering a promising strategy for cancer imaging and therapy.
- 4 December 2025
- Published by Royal Society of Chemistry (RSC) in Chemical Communications
- Vol. 61 (98) , 19461-19464
A matrix metalloproteinase-responsive iridium( iii )-based hydrogel for cancer cell-specific imaging and lysosome-targeted photodynamic therapy
A matrix metalloproteinase-sensitive iridium( iii )-based hydrogel selectively delivered lysosome-targeting iridium( iii ) complexes to cancer cells in response to elevated enzyme activity, offering a promising strategy for cancer imaging and therapy.
- Open Access
- 17 September 2025
- Published by Royal Society of Chemistry (RSC) in Chemical Science
- Vol. 16 (44) , 20931-20941
Unusual “mesoionic” N^S biscyclometallated iridium( iii ) polypyridine complexes as photosensitisers for photodynamic therapy and type II immunogenic cell death inducers
Historically, the classification of mesoionic compounds has been disconcerting, with more confusion arising when these molecules are used as ligands for metal complexes. Many mesoionic compounds are also biologically active and widely spread for various therapeutic applications, but mesoionic metal complexes have not seen much prevalence in the field. In this work, we determine the “mesoionic” nature of an unusual and rare series of N^S biscyclometallated iridium(III) complexes [Ir(N^C)2(p-ttqt)] (p-Httqt = 1-phenyl-5-thioxo-5,6-dihydro-[1,2,4]triazolo[1,5-c]quinazolin-1-ium-2-thiolate; HN^C = 2-phenylpyridine (Hppy) (1), 7,8-benzoquinoline (Hbzq) (2), 2-phenylbenzothiazole (Hbt) (3), and 2-(1-naphthyl)benzothiazole (Hbsn) (4)) as photodynamic therapy (PDT) agents and immunogenic cell death (ICD) inducers. X-ray and infrared spectroscopy studies demonstrate that the mesoionic nature is retained in the iridium(III) complexes. These complexes are ideal PDT agents with no cytotoxicity at micromolar concentrations (IC50,dark > 25 mM), shocking photocytotoxicity at nanomolar concentrations and PI values (IC50,light = 1.5 – 69 nM; PI = 362 – 33,333), and exquisite selectivity toward cancer cells. Furthermore, their localisation in the endoplasmic reticulum (ER) and efficient reactive oxygen species (ROS) generation enables them to act as photoactivated Type II ICD inducers.
- 17 September 2025
- Published by Royal Society of Chemistry (RSC) in Chemical Science
- Vol. 16 (44) , 20931-20941
Open AccessUnusual “mesoionic” N^S biscyclometallated iridium( iii ) polypyridine complexes as photosensitisers for photodynamic therapy and type II immunogenic cell death inducers
Historically, the classification of mesoionic compounds has been disconcerting, with more confusion arising when these molecules are used as ligands for metal complexes. Many mesoionic compounds are also biologically active and widely spread for various therapeutic applications, but mesoionic metal complexes have not seen much prevalence in the field. In this work, we determine the “mesoionic” nature of an unusual and rare series of N^S biscyclometallated iridium(III) complexes [Ir(N^C)2(p-ttqt)] (p-Httqt = 1-phenyl-5-thioxo-5,6-dihydro-[1,2,4]triazolo[1,5-c]quinazolin-1-ium-2-thiolate; HN^C = 2-phenylpyridine (Hppy) (1), 7,8-benzoquinoline (Hbzq) (2), 2-phenylbenzothiazole (Hbt) (3), and 2-(1-naphthyl)benzothiazole (Hbsn) (4)) as photodynamic therapy (PDT) agents and immunogenic cell death (ICD) inducers. X-ray and infrared spectroscopy studies demonstrate that the mesoionic nature is retained in the iridium(III) complexes. These complexes are ideal PDT agents with no cytotoxicity at micromolar concentrations (IC50,dark > 25 mM), shocking photocytotoxicity at nanomolar concentrations and PI values (IC50,light = 1.5 – 69 nM; PI = 362 – 33,333), and exquisite selectivity toward cancer cells. Furthermore, their localisation in the endoplasmic reticulum (ER) and efficient reactive oxygen species (ROS) generation enables them to act as photoactivated Type II ICD inducers.
- 9 September 2024
- Published by American Chemical Society (ACS) in Journal of the American Chemical Society
- Vol. 146 (37) , 25589-25599
Exploiting the Potential of Iridium(III) bis-Nitrone Complexes as Phosphorogenic Bifunctional Reagents for Phototheranostics
Cross-linking strategies have found wide applications in chemical biology, enabling the labeling of biomolecules and monitoring of protein–protein interactions. Nitrone exhibits remarkable versatility and applicability in bioorthogonal labeling due to its high reactivity with strained alkynes via the strain-promoted alkyne–nitrone cycloaddition (SPANC) reaction. In this work, four cyclometalated iridium(III) polypyridine complexes functionalized with two nitrone units were designed as novel phosphorogenic bioorthogonal reagents for bioimaging and phototherapeutics. The complexes showed efficient emission quenching, which is attributed to an efficient nonradiative decay pathway via the low-lying T1/S0 minimum energy crossing point (MECP), as revealed by computational studies. However, the complexes displayed significant emission enhancement and lifetime extension upon reaction with (1R,8S,9s)-bicyclo[6.1.0]non-4-yne (BCN) derivatives. In particular, they showed a remarkably higher reaction rate toward a bis-cyclooctyne derivative (bis-BCN) compared with its monomeric counterpart (mono-BCN). Live-cell imaging and (photo)cytotoxicity studies revealed higher photocytotoxicity in bis-BCN-pretreated cells, which is ascribed to the enhanced singlet oxygen (1O2) photosensitization resulting from the elimination of the nitrone-associated quenching pathway. Importantly, the cross-linking properties and enhanced reactivity of the complexes make them highly promising candidates for the development of hydrogels and stapled/cyclized peptides, offering intriguing photophysical, photochemical, and biological properties. Notably, a nanosized hydrogel (2-gel) demonstrated potential as a drug delivery system, while a stapled peptide (2-bis-pDIKK) exhibited p53-Mdm2 inhibitory activity related to apoptosis and a cyclized peptide (2-bis-RGD) showed cancer selectivity.
- 9 September 2024
- Published by American Chemical Society (ACS) in Journal of the American Chemical Society
- Vol. 146 (37) , 25589-25599
Exploiting the Potential of Iridium(III) bis-Nitrone Complexes as Phosphorogenic Bifunctional Reagents for Phototheranostics
Cross-linking strategies have found wide applications in chemical biology, enabling the labeling of biomolecules and monitoring of protein–protein interactions. Nitrone exhibits remarkable versatility and applicability in bioorthogonal labeling due to its high reactivity with strained alkynes via the strain-promoted alkyne–nitrone cycloaddition (SPANC) reaction. In this work, four cyclometalated iridium(III) polypyridine complexes functionalized with two nitrone units were designed as novel phosphorogenic bioorthogonal reagents for bioimaging and phototherapeutics. The complexes showed efficient emission quenching, which is attributed to an efficient nonradiative decay pathway via the low-lying T1/S0 minimum energy crossing point (MECP), as revealed by computational studies. However, the complexes displayed significant emission enhancement and lifetime extension upon reaction with (1R,8S,9s)-bicyclo[6.1.0]non-4-yne (BCN) derivatives. In particular, they showed a remarkably higher reaction rate toward a bis-cyclooctyne derivative (bis-BCN) compared with its monomeric counterpart (mono-BCN). Live-cell imaging and (photo)cytotoxicity studies revealed higher photocytotoxicity in bis-BCN-pretreated cells, which is ascribed to the enhanced singlet oxygen (1O2) photosensitization resulting from the elimination of the nitrone-associated quenching pathway. Importantly, the cross-linking properties and enhanced reactivity of the complexes make them highly promising candidates for the development of hydrogels and stapled/cyclized peptides, offering intriguing photophysical, photochemical, and biological properties. Notably, a nanosized hydrogel (2-gel) demonstrated potential as a drug delivery system, while a stapled peptide (2-bis-pDIKK) exhibited p53-Mdm2 inhibitory activity related to apoptosis and a cyclized peptide (2-bis-RGD) showed cancer selectivity.
- 10 May 2024
- Published by Royal Society of Chemistry (RSC) in Chemical Communications
- Vol. 60 (48) , 6186-6189
Construction of photofunctional peptide conjugates through selective modification of N-terminal cysteine with cyclometallated iridium(iii) 2-formylphenylboronic acid complexes for organelle-specific imaging, enzyme activity sensing and photodynamic therapy
Luminescent cyclometallated iridium(iii) complexes bearing a 2-formylphenylboronic acid moiety were designed as new N-terminal-cysteine-targeting theranostic reagents.
- 10 May 2024
- Published by Royal Society of Chemistry (RSC) in Chemical Communications
- Vol. 60 (48) , 6186-6189
Construction of photofunctional peptide conjugates through selective modification of N-terminal cysteine with cyclometallated iridium(iii) 2-formylphenylboronic acid complexes for organelle-specific imaging, enzyme activity sensing and photodynamic therapy
Luminescent cyclometallated iridium(iii) complexes bearing a 2-formylphenylboronic acid moiety were designed as new N-terminal-cysteine-targeting theranostic reagents.
- Open Access
- 24 October 2023
- Published by Royal Society of Chemistry (RSC) in Chemical Science
- Vol. 14 (46) , 13508-13517
Bioorthogonal dissociative rhenium(i) photosensitisers for controlled immunogenic cell death induction
Rhenium(i) complexes modified with a tetrazine carbamate group were designed as bioorthogonally dissociative photosensitisers for the controlled induction of immunogenic cell death (ICD) after treatment with trans-cyclooct-4-enol and light.
- 24 October 2023
- Published by Royal Society of Chemistry (RSC) in Chemical Science
- Vol. 14 (46) , 13508-13517
Open AccessBioorthogonal dissociative rhenium(i) photosensitisers for controlled immunogenic cell death induction
Rhenium(i) complexes modified with a tetrazine carbamate group were designed as bioorthogonally dissociative photosensitisers for the controlled induction of immunogenic cell death (ICD) after treatment with trans-cyclooct-4-enol and light.
- 5 October 2021
- Published by Royal Society of Chemistry (RSC) in Chemical Communications
- Vol. 57 (90) , 12008-12011
Tuning the organelle specificity and cytotoxicity of iridium(iii) photosensitisers for enhanced phototheranostic applications
Luminescent cyclometallated iridium(iii) POSS complexes were designed as efficient theranostic agents that displayed tuneable organelle-targeting properties, minimal dark cytotoxicity and substantial photocytotoxicity even under hypoxia.
- 5 October 2021
- Published by Royal Society of Chemistry (RSC) in Chemical Communications
- Vol. 57 (90) , 12008-12011
Tuning the organelle specificity and cytotoxicity of iridium(iii) photosensitisers for enhanced phototheranostic applications
Luminescent cyclometallated iridium(iii) POSS complexes were designed as efficient theranostic agents that displayed tuneable organelle-targeting properties, minimal dark cytotoxicity and substantial photocytotoxicity even under hypoxia.
- 5 March 2020
- Published by Wiley in Chempluschem
- Vol. 85 (7) , 1374-1378
Bioorthogonal Phosphorogenic Rhenium(I) Polypyridine Sydnone Complexes for Specific Lysosome Labeling
Many novel bioorthogonal reactions have been developed for labeling, such as the strain‐promoted sydnone‐alkyne cycloaddition (SPSAC), but sydnone‐based probes with phosphorogenicity (i. e., phosphorescence turn‐on upon reaction) have not been investigated to date. Herein, we report the synthesis, characterization, and photophysical properties of rhenium(I) polypyridine complexes containing a sydnone moiety as bioorthogonal phosphorogenic probes. Their reactions with strained alkyne derivatives and the associated photophysical changes were examined. Upon SPSAC with bicyclo[6.1.0]non‐4‐yn‐9‐ylmethanol (BCN‐OH), the complexes exhibited emission enhancement in the range of 8.8 to 17.3. Importantly, conjugation of the complexes with BCN‐modified bovine serum albumin (BCN‐BSA) led to the increase in emission enhancement to as high as 38.9 and extended lifetimes in the range of 1.80 to 4.71 μs. Additionally, the bioorthogonal ligation of one of the complexes with a morpholine derivative was shown to induce specific lysosomal labeling in live cells; colocalization studies with LysoTracker Deep Red indicated a Pearson's coefficient of 0.83.
- 5 March 2020
- Published by Wiley in Chempluschem
- Vol. 85 (7) , 1374-1378
Bioorthogonal Phosphorogenic Rhenium(I) Polypyridine Sydnone Complexes for Specific Lysosome Labeling
Many novel bioorthogonal reactions have been developed for labeling, such as the strain‐promoted sydnone‐alkyne cycloaddition (SPSAC), but sydnone‐based probes with phosphorogenicity (i. e., phosphorescence turn‐on upon reaction) have not been investigated to date. Herein, we report the synthesis, characterization, and photophysical properties of rhenium(I) polypyridine complexes containing a sydnone moiety as bioorthogonal phosphorogenic probes. Their reactions with strained alkyne derivatives and the associated photophysical changes were examined. Upon SPSAC with bicyclo[6.1.0]non‐4‐yn‐9‐ylmethanol (BCN‐OH), the complexes exhibited emission enhancement in the range of 8.8 to 17.3. Importantly, conjugation of the complexes with BCN‐modified bovine serum albumin (BCN‐BSA) led to the increase in emission enhancement to as high as 38.9 and extended lifetimes in the range of 1.80 to 4.71 μs. Additionally, the bioorthogonal ligation of one of the complexes with a morpholine derivative was shown to induce specific lysosomal labeling in live cells; colocalization studies with LysoTracker Deep Red indicated a Pearson's coefficient of 0.83.
- Open Access
- 17 April 2019
- Published by Royal Society of Chemistry (RSC) in Dalton Transactions
- Vol. 48 (26) , 9831
Correction: Iridium(iii) polypyridine complexes with a disulfide linker as biological sensors and cytotoxic agents
Correction for ‘Iridium(III) polypyridine complexes with a disulfide linker as biological sensors and cytotoxic agents’ by Steve Po-Yam Li et al., Dalton Trans., 2019, DOI: 10.1039/c9dt00793h.
- 17 April 2019
- Published by Royal Society of Chemistry (RSC) in Dalton Transactions
- Vol. 48 (26) , 9831
Open AccessCorrection: Iridium(iii) polypyridine complexes with a disulfide linker as biological sensors and cytotoxic agents
Correction for ‘Iridium(III) polypyridine complexes with a disulfide linker as biological sensors and cytotoxic agents’ by Steve Po-Yam Li et al., Dalton Trans., 2019, DOI: 10.1039/c9dt00793h.